Quantitative MRI measures of orbitofrontal cortex in patients with chronic schizophrenia or schizoaffective disorder

Psychiatry Research - Neuroimaging

Volumn 140, Issue 2, 2005, Pages 133-145

  Hoptman, Matthew J ^a,b   Volavka, Jan ^a,b   Weiss, Elisabeth M ^c   Czobor, Pál ^a,d   Szeszko, Philip R ^e   Gerig, Guido ^f   Chakos, Miranda ^g   Blocher, Joseph ^f   Citrome, Leslie L ^a,b   Lindenmayer, Jean Pierre ^a,b,h   Sheitman, Brian ⁱ   Lieberman, Jeffrey A ^f   Bilder, Robert M ^j  

^a NATHAN S KLINE INSTITUTE FOR PSYCHIATRIC RESEARCH   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF INNSBRUCK   (Austria)

^d DOV Pharmaceuticals   (United States)

^e ZUCKER HILLSIDE HOSPITAL   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g SUNY DOWNSTATE MEDICAL CENTER   (United States)

^h MANHATTAN PSYCHIATRIC CENTER   (United States)

ⁱ Dorothea Dix Hospital   (United States)

^j UNIVERSITY OF CALIFORNIA   (United States)

more..

Author keywords

Aggression; Neuropsychological function; Orbitofrontal cortex; Schizophrenia

Indexed keywords

ADULT; AGGRESSION; ARTICLE; BRAIN SIZE; CONTROLLED STUDY; FEMALE; GRAY MATTER; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PATIENT; NEUROANATOMY; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBITAL CORTEX; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYMPTOMATOLOGY; WHITE MATTER;

ADULT; AGGRESSION; BASAL GANGLIA DISEASES; CHRONIC DISEASE; COGNITION DISORDERS; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; POSITRON-EMISSION TOMOGRAPHY; PREFRONTAL CORTEX; PSYCHOTIC DISORDERS; QUESTIONNAIRES; SCHIZOPHRENIA;

EID: 27544443815     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pscychresns.2005.07.004     Document Type: Article

References (61)

1. C. Arango, A. Breier, R. McMahon, W.T. Carpenter Jr., and R.W. Buchanan The relationship of clozapine and haloperidol treatment response to prefrontal, hippocampal, and caudate brain volumes American Journal of Psychiatry 160 2003 1421 1427
2. W.F.C. Baaré, H.E.H. Pol, R. Hijman, W.P.Th. Mali, M.A. Viergever, and R.S. Kahn Volumetric analysis of frontal lobe regions in schizophrenia: relation to cognitive function and symptomatology Biological Psychiatry 45 1999 1597 1605
3. A. Bechara, A.R. Damasio, H. Damasio, and S.W. Anderson Insensitivity to future consequences following damage to human prefrontal cortex Cognition 50 1994 7 15
4. F.M. Benes, P.A. Paskevich, J. Davidson, and V.B. Domesick Synaptic rearrangements in medial prefrontal cortex of haloperidol-treated rats Brain Research 348 1985 15 20
5. F.M. Benes, P.A. Paskevich, J. Davidson, and V.B. Domesick The effects of haloperidol on synaptic patterns in the rat striatum Brain Research 329 1985 265 274
6. R.M. Bilder, R.S. Goldman, J. Volavka, P. Czobor, M. Hoptman, B. Sheitman, J.-P. Lindenmayer, L. Citrome, J. McEvoy, M. Kunz, M. Chakos, T.B. Cooper, T.L. Horwitz, and J.A. Lieberman Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol on treatment-resistant patients with schizophrenia and schizoaffective disorder American Journal of Psychiatry 159 2002 1018 1028
7. R.M. Bilder, J. Volavka, P. Czobor, A.K. Malhotra, J.L. Kennedy, X. Ni, R.S. Goldman, M.J. Hoptman, B. Sheitman, J.-P. Lindenmayer, L. Citrome, J. McEvoy, M. Kunz, M. Chakos, T.B. Cooper, and J.A. Lieberman Neurocognitive correlates of the COMT Val158Met polymorphism in chronic schizophrenia Biological Psychiatry 52 2002 701 707
8. M.H. Chakos, J.A. Lieberman, R.M. Bilder, M. Borenstein, G. Lerner, B. Bogerts, H. Wu, B. Kinon, and M. Ashtari Increase in caudate nuclei volumes of first-episode schizophrenic patients taking antipsychotic drugs American Journal of Psychiatry 151 1994 1430 1436
9. M.H. Chakos, J.A. Lieberman, J. Alvir, R. Bilder, and M. Ashtari Caudate nuclei volumes in schizophrenic patients treated with typical antipsychotics or clozapine Lancet 345 1995 456 457
10. M. Chakos, O. Shirakawa, J. Lieberman, H. Lee, R. Bilder, and C.A. Tamminga Striatal enlargement in rats chronically treated with neuroleptic Biological Psychiatry 44 1998 675 684
11. G. Chouinard, A. Ross-Chouinard, L. Annable, and B. Jones Extrapyramidal Symptom Rating Scale Canadian Journal of Neurological Sciences 7 1980 233 (Abstract)
12. L. Citrome, J. Volavka, P. Czobor, B. Sheitman, J.-P. Lindenmayer, J. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia Psychiatric Services 52 2001 1510 1514
13. L. Citrome, D.E. Casey, D.G. Daniel, P. Wozniak, L.D. Kochan, and K.D. Tracy Adjunctive divalproex and hostility among patients with schizophrenia receiving olanzapine or risperidone Psychiatric Services 55 2004 290 294
14. A. Convit, O.T. Wolf, M.J. de Leon, M. Patalinjug, E. Kandil, C. Caraos, A. Scherer, L.A. Saint Louis, and R. Cancro Volumetric analysis of pre-frontal regions: findings in aging and schizophrenia Psychiatry Research: Neuroimaging 107 2001 61 73
15. P. Czobor, J. Volavka, and R.C. Meibach Effect of risperidone on hostility in schizophrenia Journal of Clinical Psychopharmacology 15 1995 243 249
16. L.E. DeLisi, A.L. Hoff, J.E. Schwartz, G.W. Shields, S.N. Halthore, S. Gupta, F.A. Henn, and A.K. Anand Brain morphology in first-episode schizophrenia-like psychotic patients: a quantitative magnetic resonance imaging study Biological Psychiatry 28 1991 159 175
17. M.B. First, R.L. Spitzer, M. Gibbon, and J.B.W. Williams Structured Clinical Interview for DSM-IV Axis-I Disorders: SCID Clinician Version 1995 Biometrics Research Department, New York State Psychiatric Institute, Department of Psychiatry Columbia University, New York
18. J.A. Frazier, J.N. Giedd, D. Kaysen, K. Albus, S. Hamburger, J. Alaghband-Rad, M.C. Lenane, K. McKenna, A. Breier, and J.L. Rapoport Childhood-onset schizophrenia: brain MRI after 2 years of clozapine maintenance treatment American Journal of Psychiatry 153 1996 546 566
19. H. Garavan, T.J. Ross, and E.A. Stein Right hemispheric dominance of inhibitory control: an event-related functional MRI study Proceedings of the National Academy of Sciences of the United States of America 96 1999 8301 8306
20. R.Z. Goldstein, and N.D. Volkow Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex American Journal of Psychiatry 2002 1642 1652
21. R.Z. Goldstein, N.D. Volkow, G.J. Wang, J.S. Fowler, and S. Rajaram Addiction changes orbitofrontal gyrus function: involvement in response inhibition NeuroReport 12 2001 2595 2599
22. J. Grafman, K. Schwab, D. Warden, A. Pridgen, H.R. Brown, and A.M. Salazar Frontal lobe injuries, violence, and aggression: a report of the Vietnam Head Injury Study Neurology 46 1996 1231 1238
23. R.E. Gur, P.E. Cowell, E. Lattuada, B.I. Turetsky, R.I. Grossman, S.E. Arnold, W.B. Bilker, and R.C. Gur Reduced dorsal and orbital prefrontal gray matter volumes in schizophrenia Archives of General Psychiatry 57 2000 761 768
24. J.M. Harlow Recovery from the passage of an iron bar through the head Publications of the Massachusetts Medical Society 2 1868 329 348
25. S. Heckers, H. Heinsen, Y. Heinsen, and H. Beckmann Cortex, white matter, and basal ganglia in schizophrenia: a volumetric postmortem study Biological Psychiatry 29 1991 556 566
26. M.J. Hoptman Neuroimaging studies of violence and antisocial behavior Journal of Psychiatric Practice 9 2003 265 278
27. M.J. Hoptman, J. Volavka, G. Johnson, E. Weiss, R.M. Bilder, and K.O. Lim Frontal white matter, aggression and impulsivity in men with schizophrenia Biological Psychiatry 52 2002 9 14
28. M.J. Hoptman, B.A. Ardekani, P.D. Butler, J. Nierenberg, D.C. Javitt, and K.O. Lim DTI and impulsivity in schizophrenia: a first voxelwise correlational study Biological Psychiatry 15 2004 2467 2470
29. Hoptman, M.J., Volavka, J., Czobor, P., Gerig, G., Chakos, M., Blocher, J., Citrome, L.L., Sheitman, B., Lindenmayer, J.-P., Lieberman, J.A., Bilder, R.M. Aggression and quantitative MRI measures of caudate in patients with chronic schizophrenia or schizoaffective disorder, manuscript submitted for publication.
30. T.L. Jernigan, S. Zisook, R.K. Heaton, J.T. Moranville, J.R. Hesselink, and D.L. Braff Magnetic resonance imaging abnormalities in lenticular nuclei and cerebral cortex in schizophrenia Archives of General Psychiatry 48 1991 881 890
31. D.V. Jeste, J.B. Lohr, J.H. Eastham, E. Rockwell, and M.P. Caligiuri Adverse neurobiological effects of long-term use of neuroleptics: human and animal studies Journal of Psychiatric Research 32 1998 201 214
32. Y. Kawasaki, M. Suzuki, S. Nohara, H. Hagino, T. Takahashi, M. Matsui, I. Yamashita, X.A. Chitnis, P.K. McGuire, H. Seto, and M. Kurachi Structural brain differences in patients with schizophrenia and schizotypal disorder demonstrated by voxel-based morphometry European Archives of Psychiatry and Clinical Neuroscience 254 2004 406 414
33. S.R. Kay, L.A. Opler, and A. Fiszbein Positive and Negative Syndrome Scale (PANSS) 1986 Bronx Psychiatric Center Bronx, N.Y.
34. M.S. Keshavan, W.W. Bagwell, G.L. Haas, J.A. Sweeney, N.R. Schooler, and J.W. Pettegrew Changes in caudate volume with neuroleptic treatment Lancet 344 1994 1434
35. H. Komuro, and P. Rakic Modulation of neuronal migration by NMDA receptors Science 260 1993 95 97
36. D.J. Lang, L.C. Kopala, R.A. Vandrope, Q. Rui, G.N. Smith, V.M. Goghari, and W.G. Honer An MRI study of basal ganglia volumes in first-episode schizophrenia patients treated with risperidone American Journal of Psychiatry 158 2001 625 631
37. P.F. Liddle, K.A. Kiehl, and A.M. Smith Event-related fMRI study of response inhibition Human Brain Mapping 12 2001 100 109
38. K.O. Lim, S.J. Choi, N. Pomara, A. Wolkin, and J.P. Rotrosen Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study Biological Psychiatry 51 2002 890 895
39. D.H. Mathalon, A. Pfefferbaum, K.O. Lim, M.J. Rosenbloom, and E.V. Sullivan Compounded brain volume deficits in schizophrenia-alcoholism comorbidity Archives of General Psychiatry 60 2003 245 252
40. V. Molina, J. Sanz, C. Benito, and T. Palomo Direct association between orbitofrontal atrophy and the response of psychotic symptoms to olanzapine in schizophrenia International Clinical Psychopharmacology 19 2004 221 228
41. M.A. Niznikiewicz, M. Kubicki, and M.E. Shenton Recent structural and functional imaging findings in schizophrenia Current Opinion in Psychiatry 16 2003 123 147
42. M. Ono, S. Kubik, and C.D. Abernathey Atlas of the Cerebral Sulci 1990 Thieme Medical Publishers New York
43. C. Pantelis, D. Velakoulis, P.D. McGorry, S.J. Wood, J. Suckling, L.J. Phillips, A.R. Yung, E.T. Bullmore, W. Brewer, B. Soulsby, P. Desmond, and P.K. McGuire Neuroanatomical abnormalities before and after onset of psychosis: a cross-sectional and longitudinal MRI comparison Lancet 361 2002 281 288
44. G.D. Pearlson, and L. Marsh Structural brain imaging in schizophrenia: a selective review Biological Psychiatry 46 1999 627 649
45. A. Raine, T. Lencz, S. Bihrle, L. LaCasse, and P. Colletti Reduced prefrontal gray matter volume and reduced autonomic activity in antisocial personality disorder Archives of General Psychiatry 57 2000 119 127
46. E.T. Rolls The orbitofrontal cortex and reward Cerebral Cortex 10 2000 284 294
47. K. Rubia, T. Russell, E.T. Bullmore, W. Soni, M.J. Brammer, A. Simmons, E. Taylor, C. Andrew, V. Giampietro, and T. Sharma An fMRI study of reduced left prefrontal activation in schizophrenia during normal inhibitory function Schizophrenia Research 52 2001 47 55
48. C.I. Rupp, W.W. Fleischhacker, G. Kemmler, C. Kremser, R.M. Bilder, S. Mechtcheriakov, P.R. Szeszko, T. Walch, A.W. Scholtz, M. Klimbacher, C. Maier, G. Albrecht, T. Lechner-Schoner, S. Felber, and H. Hinterhuber Olfactory functions and volumetric measures of orbitofrontal and limbic regions in schizophrenia Schizophrenia Research 74 2005 149 161
49. M.E. Shenton, C.C. Dickey, M. Frumin, and R.W. McCarley A review of MRI findings in schizophrenia Schizophrenia Research 49 2001 1 52
50. D.A. Silbersweig, E. Stern, C. Frith, C. Cahill, A. Holmes, S. Grootoonk, J. Seaward, P. McKenna, S.E. Chua, and L. Schnorr A functional neuroanatomy of hallucinations in schizophrenia Nature 378 1995 176 179
51. J.M. Silver, and S.C. Yudofsky The Overt Aggression Scale: overview and guiding principles Journal of Neuropsychiatry and Clinical Neurosciences 3 1991 S22 S29
52. V.W. Swayze II, N.C. Andreasen, R.J. Alliger, W.T.C. Yuh, and J.C. Erhardt Subcortical and temporal structures in affective disorder and schizophrenia: a magnetic resonance imaging study Biological Psychiatry 31 1992 221 240
53. P.R. Szeszko, R.M. Bilder, T. Lencz, S. Pollack, J.Ma.J. Alvir, M. Ashtari, H. Wu, and J.A. Lieberman Investigation of frontal lobe subregions in first-episode schizophrenia Psychiatry Research: Neuroimaging 90 1999 1 15
54. J. Talairach, and P. Tournoux Co-Planar Stereotaxic Atlas of the Human Brain: Three-Dimensional Proportional System: An Approach to Cerebral Imaging 1988 Thieme Medical Publishers Inc. New York
55. J. Volavka, P. Czobor, B. Sheitman, J.P. Lindenmayer, L. Citrome, J. McEvoy, T.B. Cooper, M. Chakos, and J.A. Lieberman Clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia and schizoaffective disorder American Journal of Psychiatry 159 2002 255 262
56. J. Volavka, P. Czobor, K. Nolan, B. Sheitman, J.-P. Lindenmayer, L. Citrome, J.P. McEvoy, T.B. Cooper, and J.A. Lieberman Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol Journal of Clinical Psychopharmacology 24 2004 225 228
57. N.D. Volkow, G.-J. Wang, J.S. Fowler, R. Hitzemann, B. Angrist, S.J. Gatley, J. Logan, Y.-S. Ding, and N. Pappas Association of methylphenidate- induced craving with changes in right striato-orbitofrontal metabolism in cocaine abusers: implications in addiction American Journal of Psychiatry 156 1999 19 26
58. N. Volkow, J. Fowler, G. Wang, and R. Goldstein Role of dopamine, the frontal cortex and memory circuits in drug addiction: insight from imaging studies Neurobiology of Learning and Memory 78 2002 610 624
59. F.X. Vollenweider, K.L. Leenders, I. Oye, D. Hell, and J. Angst Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET) European Neuropsychopharmacology 7 1997 25 38
60. F.G. Woermann, L.T. van Elst, M.J. Koepp, S.L. Free, P.J. Thompson, M.R. Trimble, and J.S. Duncan Reduction of frontal neocortical grey matter associated with affective aggression in patients with temporal lobe epilepsy: an objective voxel by voxel analysis of automatically segmented MRI Journal of Neurology, Neurosurgery and Psychiatry 68 2000 162 169
61. S.C. Yudofsky, J.M. Silver, W. Jackson, J. Endicott, and D. Williams The Overt Aggression Scale for the objective rating of verbal and physical aggression American Journal of Psychiatry 143 1986 35 39